Comments
Loading...
Tourmaline Bio (TRML) Forecast
NewsEarningsTourmaline Bio (TRML) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestTourmaline Bio (NASDAQ:TRML) Stock Quotes, Forecast and News Summary
Tourmaline Bio Stock (NASDAQ: TRML) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Tourmaline Bio (TRML) stock?
You can purchase shares of Tourmaline Bio (NASDAQ:TRML) through any online brokerage.
Who are Tourmaline Bio (TRML) competitors?
Other companies in Tourmaline Bio’s space includes: Tectonic Therapeutic (NASDAQ:TECX), Immunome (NASDAQ:IMNM), Humacyte (NASDAQ:HUMA), Replimune Group (NASDAQ:REPL) and Altimmune (NASDAQ:ALT).
What is the forecast, or price target, for Tourmaline Bio (TRML) stock?
Tourmaline Bio has a consensus price target of $62.00.
What is the current price for Tourmaline Bio (TRML)?
The stock price for Tourmaline Bio (NASDAQ: TRML) is $22.96 last updated November 21, 2024 at 11:00 AM EST.
Does Tourmaline Bio (TRML) pay a dividend?
There are no upcoming dividends for Tourmaline Bio.
When is Tourmaline Bio (NASDAQ:TRML) reporting earnings?
Tourmaline Bio’s Q3 earnings are confirmed for Thursday, November 7, 2024.
Is Tourmaline Bio (TRML) going to split?
There is no upcoming split for Tourmaline Bio.
What sector and industry does Tourmaline Bio (TRML) operate in?
Tourmaline Bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.